Lilian Shackelford Murray
CIK: 0001743173
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RKDA
Arcadia Biosciences, Inc.
Director
Discretionary Trading P&L
Holdings
About Murray Lilian Shackelford
Murray Lilian Shackelford (SEC CIK 0001743173) files insider reports with the SEC as Director of Arcadia Biosciences, Inc. (RKDA).
Signal8 holds 1 ownership filing by Murray Lilian Shackelford, a Form 4, filed on Sep 14, 2026. Those filings report 1 transaction, the latest on Sep 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Murray Lilian Shackelford's filings is in DALLAS, TX.
Recent filings by Murray Lilian Shackelford
- Sep 10, 2026: Grant or award of RKDA derivative securities (Form 4, code A).
Other insiders filing for Arcadia Biosciences, Inc. (RKDA)
- Yoder Amy, Director
- Comcowich Kevin, Director
- WALLER GREGORY D, Director
- Kawakami Mark, Chief Financial Officer
- Schaefer Thomas J., Chief Executive Officer